IMT-18

N/A

Report date: 2024/11/07 16:30:24

Base Information

Drug NameIMT-18
Drug Alias NameIMT-18
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunoglobulin superfamily member 11 inhibitors
TargetsImmunoglobulin superfamily member 11
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIOmx Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesIOmx Therapeutics AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A